IL6 and systemic sclerosis: The lack of apparent inflammatory lesions in the kidneys during SRC may be related to the fact that pro-inflammatory effects of IL-6 are seen only during a specific stage of SSc [30] and serum IL-6 levels decrease gradually with disease duration [31].